MWV Acquires AARDEX Group

MeadWestvaco Corporation MWV announced today that it is expanding its leading position in adherence packaging with the acquisition of AARDEX Group SA. AARDEX Group is the leader and pioneer in the design and use of electronic medication event monitoring systems and applications designed to measure, analyze, and manage patient adherence in clinical drug trials. “This acquisition builds on MWV's long-standing commitment and scientific approach to showing medication packaging's impact as an important adherence intervention,” said Bruce Thomas, president, MWV Healthcare and Senior Vice President, Global Innovation. “We recognize the critical global need to create packaging solutions that address the issue of medication non-adherence. With the acquisition of AARDEX Group, MWV will now be able to provide customers with a complete range of packaging, data analysis and service solutions that address non-adherence to medications, from phase II clinical trials all the way through commercialization.”
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsM&A
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!